Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
Status:
Completed
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This is a phase 0/phase I feasibility trial to test the hypothesis that flaxseed
supplementation is an effective maintenance therapy for patients with ovarian cancer who are
in clinical remission following platinum-based regimens. The investigators further
hypothesize levels of estrogen metabolites and prostaglandin E2 in this patient population
will correlate with recurrence of disease, extent of tumor burden, invasion and metastasis.